BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6189274)

  • 21. Androgen receptor assay in human benign and malignant prostatic tumour cytosol using protamine sulphate precipitation.
    Mobbs BG; Johnson IE; Connolly JG; Clark AF
    J Steroid Biochem; 1978 Apr; 9(4):289-301. PubMed ID: 77938
    [No Abstract]   [Full Text] [Related]  

  • 22. Are adrenal and testicular androgen levels correlated?
    Georgiadis EI; Matzoros C; Aliferis C; Batrinos M
    Horm Metab Res; 1992 Oct; 24(10):488-91. PubMed ID: 1464416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects on the endocrine system of long-term treatment with the non-steroidal anti-androgen Casodex in patients with benign prostatic hyperplasia.
    Eri LM; Haug E; Tveter KJ
    Br J Urol; 1995 Mar; 75(3):335-40. PubMed ID: 7537602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Androgen and SHBG serum concentrations in late post-menopause women.
    Skałba P; Wójtowicz M; Sikora J
    Med Sci Monit; 2003 Mar; 9(3):CR152-6. PubMed ID: 12640346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prostatic cytoplasmic androgen receptor in prostatic disease. I. Serum androgen levels, cytoplasmic androgen levels and cytoplasmic R1881 receptor in prostatic disease].
    Kitano T
    Nihon Hinyokika Gakkai Zasshi; 1984 Jul; 75(7):1084-97. PubMed ID: 6334192
    [No Abstract]   [Full Text] [Related]  

  • 26. 3 alpha-Androstanediol glucuronide in premature and normal pubarche.
    Riddick LM; Garibaldi LR; Wang ME; Senne AR; Klimah PE; Clark AT; Levine LS; Oberfield SE; Pang SY
    J Clin Endocrinol Metab; 1991 Jan; 72(1):46-50. PubMed ID: 1846006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of basal and adrenocorticotropin-stimulated plasma levels of adrenal androgens after treatment with an antiandrogen in castrated patients with prostatic cancer.
    Bélanger A; Dupont A; Labrie F
    J Clin Endocrinol Metab; 1984 Sep; 59(3):422-6. PubMed ID: 6086697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adrenopause or decline of serum adrenal androgens with age in women living at sea level or at high altitude.
    Gonzales GF; Góñez C; Villena A
    J Endocrinol; 2002 Apr; 173(1):95-101. PubMed ID: 11927388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Androgen, progestin and estrogen receptors in the normal human prostate and in pathology].
    Gerasimova TsI; Smirnov AN; Rozen VB; Buniatian AF; Bol'shakova TD
    Sov Med; 1984; (6):32-6. PubMed ID: 6205454
    [No Abstract]   [Full Text] [Related]  

  • 30. Androgen cytosol binding during compensatory overload-induced skeletal muscle hypertrophy.
    Hickson RC; Kurowski TT; Galassi TM; Daniels DG; Chatterton RJ
    Can J Biochem Cell Biol; 1985 May; 63(5):348-54. PubMed ID: 3874677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlations of basal oestrogens with adrenal androgens and relative weight in normal women.
    Ellison PT
    Ann Hum Biol; 1984; 11(4):327-36. PubMed ID: 6235769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of plasma androgen and estrogen concentrations in ferrets with hyperadrenocorticism.
    Rosenthal KL; Peterson ME
    J Am Vet Med Assoc; 1996 Sep; 209(6):1097-102. PubMed ID: 8800255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dihydrotestosterone-binding characteristics in human prostatic adenoma].
    Gerasimova TsI; Smirnov AN; Buniatian AF
    Probl Endokrinol (Mosk); 1982; 28(5):37-42. PubMed ID: 6183657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous sex hormone levels in postmenopausal women undergoing carotid artery endarterectomy.
    Debing E; Peeters E; Duquet W; Poppe K; Velkeniers B; Van den Brande P
    Eur J Endocrinol; 2007 Jun; 156(6):687-93. PubMed ID: 17535869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of mepartricin on estradiol and testosterone serum levels and on prostatic estrogen, androgen and adrenergic receptor concentrations in adult rats.
    Re G; Badino P; Odore R; Vigo D; Bonabello A; Rabino S; Capello F; Bruzzese T
    Pharmacol Res; 2001 Aug; 44(2):141-7. PubMed ID: 11516265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Importance of determining steroid hormone receptors and the treatment of prostatic cancer].
    Fedotov IA; Denisov LE; Kozlov VP; Degtiar' VG
    Urol Nefrol (Mosk); 1983; (1):63-70. PubMed ID: 6187115
    [No Abstract]   [Full Text] [Related]  

  • 37. Androgen receptor content of normal and hyperplastic human prostate.
    Trachtenberg J; Bujnovszky P; Walsh PC
    J Clin Endocrinol Metab; 1982 Jan; 54(1):17-21. PubMed ID: 6172440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hirsutism: diagnostic approach and stimulation-suppression dynamics of androgens in the female.
    Biberoglu K; Behrman SJ
    Int J Fertil; 1982; 27(3):146-52. PubMed ID: 6128319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and measurement of the androgen receptor in human benign prostatic hyperplasia and prostatic hyperplasia and prostatic carcinoma.
    Snochowski M; Pousette A; Ekman P; Bression D; Andersson L; Högberg B; Gustafsson JA
    J Clin Endocrinol Metab; 1977 Nov; 45(5):920-30. PubMed ID: 72758
    [No Abstract]   [Full Text] [Related]  

  • 40. Decreased androgen concentrations and diminished general and sexual well-being in women with premature ovarian failure.
    van der Stege JG; Groen H; van Zadelhoff SJ; Lambalk CB; Braat DD; van Kasteren YM; van Santbrink EJ; Apperloo MJ; Weijmar Schultz WC; Hoek A
    Menopause; 2008; 15(1):23-31. PubMed ID: 18257141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.